Pfizer’s vaccine is already in the FDA approval process and Moderna CEO Stéphane Bancel told CNBC from Davos on Wednesday that it will be filing for FDA approval for its vaccine soon — it even had a plan in place for top executives to be ready to submit over the holidays if needed.
...researchers have found that viruses that surge in the winter, including influenza viruses and SARS-CoV-2 — the coronavirus that causes COVID-19 — survive best when the relative humidity in the air falls below about 40 percent.
A combined vaccine for influenza and COVID-19 has the potential to simplify immunization practices against two severe respiratory diseases caused by evolving viruses that require vaccine adaptation.
...Though the three respiratory viruses all share certain symptoms, there are some key differences that can help patients differentiate which illnesses they may be dealing with, according to the CDC.
Recent Comments